Open AccessTriple Combination Prolongs Survival in Advanced BRAF V600 Melanoma
Author(s) -
Warren Froelich
Publication year - 2020
Publication title -
oncology times
Language(s) - Slovenian
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000681600.37206.92
Subject(s) - melanoma , medicine , cancer , mek inhibitor , trametinib , immune checkpoint , cancer research , kinase , combination therapy , targeted therapy , immune system , dabrafenib , oncology , mapk/erk pathway , immunotherapy , metastatic melanoma , immunology , biology , vemurafenib , microbiology and biotechnology